In an effort to effectively address global health concerns, the WHO has announced the 13th General Programme of Work, a 5-year strategic plan spanning from 2019 to 2023.
Because of the relative rarity of stroke in children, many clinicians tend to presume that mimics are the cause of the symptoms.
Pharmacologic interventions including oral and injected drugs are a mainstay of spasticity management; however, drug therapies alone are not considered sufficient, and the general consensus supports a broader therapeutic strategy.
The main objection among clinical researchers is that commercially developed products often lack a scientific basis for their selection of features.
In the past, many epilepsy providers have focused solely on seizure control as a way to improve developmental outcomes and HRQOL; however, we now know that the most effective treatment for pediatric epilepsy is comprehensive.
Rosalind C. Kalb, PhD, a clinical psychologist, offers her insights on how clinicians can address patient concerns about reproductive issues and MS.
The comorbid presence of central apnea has been identified by multiple researchers as predictive of SUDEP.
There are many procedural treatments for migraine that are effective and safe, including peripheral nerve blocks, trigger point injections, botulinum toxin injections, and sphenopalatine ganglion blocks.
Neurology Advisor spoke with Jacob Levitt, MD, for his unique medical and patient perspectives on PP.
Pediatric MS is predominantly inflammatory in nature, with a presentation that is similar to a number of other conditions.
